Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SRIDHAR CHATRATHI

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1447239561
CMS profile
20350
Location
GREENBELT, MD

General Payments · PY2018–2024

$7,441.05

  • Reported across 273 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$376.27

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $376.27 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $116.88 6
Abbott Laboratories $80.55 1
Lilly USA, LLC $58.54 3
NOVARTIS PHARMACEUTICALS CORPORATION $51.11 2
BIOTRONIK INC. $46.23 2
PFIZER INC. $22.96 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,735.91 61
PY2019 $558.97 37
PY2020 $1,395.63 59
PY2021 $1,771.43 75
PY2022 $350.21 14
PY2023 $252.63 12
PY2024 $376.27 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $80.55 01/02/2024 Food and Beverage Undisputed 01/23/2026 1125068911 CMS
BIOTRONIK INC. $26.41 04/02/2024 Food and Beverage Undisputed 01/23/2026 1145802753 CMS
BIOTRONIK INC. $19.82 07/02/2024 Food and Beverage Undisputed 01/23/2026 1145802765 CMS
Lilly USA, LLC $21.48 01/24/2024 Food and Beverage Undisputed 01/23/2026 1135428983 CMS
Lilly USA, LLC $18.48 03/01/2024 Food and Beverage Undisputed 01/23/2026 1135410609 CMS
Lilly USA, LLC $18.58 03/06/2024 Food and Beverage Undisputed 01/23/2026 1135349479 CMS
Novartis Pharmaceuticals Corporation $20.35 04/05/2024 Food and Beverage Undisputed 01/23/2026 1086741333 CMS
Novartis Pharmaceuticals Corporation $30.76 07/31/2024 Food and Beverage Undisputed 01/23/2026 1086741341 CMS
Novo Nordisk Inc $19.31 02/22/2024 Food and Beverage Undisputed 01/23/2026 1097297746 CMS
Novo Nordisk Inc $19.52 04/30/2024 Food and Beverage Undisputed 01/23/2026 1097813420 CMS
Novo Nordisk Inc $23.97 05/09/2024 Food and Beverage Undisputed 01/23/2026 1096669440 CMS
Novo Nordisk Inc $17.02 05/17/2024 Food and Beverage Undisputed 01/23/2026 1097334553 CMS
Novo Nordisk Inc $17.82 09/24/2024 Food and Beverage Undisputed 01/23/2026 1097765865 CMS
Novo Nordisk Inc $19.24 12/16/2024 Food and Beverage Undisputed 01/23/2026 1096885831 CMS
PFIZER INC. $22.96 02/14/2024 Food and Beverage Undisputed 01/23/2026 1131010315 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.